NPX887

· NextPoint Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NPX887, covering 2025-06-27 to 2025-06-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2 [Phase 1]